indole has been researched along with Hepatocellular Carcinoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Subsequently, we screened their cytotoxicity via CCK-8 assay in HepG2 cells, a human hepatoma cell line and chose compound 4p that showed the lowest dosage of IC50 to study the antitumor activities to HCC." | 5.48 | Oral administration of indole substituted dipyrido[2,3-d]pyrimidine derivative exhibits anti-tumor activity via inhibiting AKT and ERK1/2 on hepatocellular carcinoma. ( Cen, L; Gao, X; Li, F; Wen, R; Yan, H; Yao, H; Zhu, S, 2018) |
| " Subsequently, we screened their cytotoxicity via CCK-8 assay in HepG2 cells, a human hepatoma cell line and chose compound 4p that showed the lowest dosage of IC50 to study the antitumor activities to HCC." | 1.48 | Oral administration of indole substituted dipyrido[2,3-d]pyrimidine derivative exhibits anti-tumor activity via inhibiting AKT and ERK1/2 on hepatocellular carcinoma. ( Cen, L; Gao, X; Li, F; Wen, R; Yan, H; Yao, H; Zhu, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X | 1 |
| Cen, L | 1 |
| Li, F | 1 |
| Wen, R | 1 |
| Yan, H | 1 |
| Yao, H | 1 |
| Zhu, S | 1 |
| Długosz, A | 1 |
| Gach, K | 1 |
| Szymański, J | 1 |
| Modranka, J | 1 |
| Janecki, T | 1 |
| Janecka, A | 1 |
2 other studies available for indole and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Oral administration of indole substituted dipyrido[2,3-d]pyrimidine derivative exhibits anti-tumor activity via inhibiting AKT and ERK1/2 on hepatocellular carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Lin | 2018 |
Anticancer activity of new molecular hybrids combining 1,4-naphthalenedione motif with phosphonic acid moiety in hepatocellular carcinoma HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; DNA Damage; Furans; Hep G2 Cells; Human | 2017 |